The importance of making ends meet: Mutations in genes and altered expression of proteins of the MRN complex and cancer

Mutation Research - Reviews in Mutation Research

Volumn 659, Issue 3, 2008, Pages 262-273

  Dzikiewicz Krawczyk, Agnieszka ^a  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

Author keywords

Carcinogenesis; Double strand break repair; MRE11; NBS1; RAD50

Indexed keywords

MRE11 PROTEIN; NIBRIN; RAD50 PROTEIN;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; GENE MUTATION; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HUMAN; LEUKEMIA; LYMPHOMA; MICROSATELLITE INSTABILITY; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

CELL CYCLE PROTEINS; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; GENE EXPRESSION; HETEROZYGOTE; HUMANS; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS; NUCLEAR PROTEINS;

EID: 50049099559     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2008.05.005     Document Type: Review

References (103)

1. Scott S.P., and Pandita T.K. The cellular control of DNA double-strand breaks. J. Cell Biochem. 99 (2006) 1463-1475
2. Wyman C., and Kanaar R. DNA double-strand break repair: all's well that ends well. Annu. Rev. Genet. 40 (2006) 363-383
3. Petrini J.H.J., and Stracker T.H. The cellular response to DNA double-strand breaks: defining the sensors and mediators. Trends Cell Biol. 13 (2003) 458-462
4. Kobayashi J. Molecular mechanism of the recruitment of NBS1/hMRE1/hRAD50 complex to DNA double-strand breaks: NBS1 binds to γ-H2AX through FHA/BRCT domain. J. Radiat. Res. 45 (2004) 473-478
5. Stavridi E.S., and Halazonetis T.D. Nbs1 moving up in the world. Nat. Cell Biol. 7 (2005) 648-650
6. D'Amours D., and Jackson S.P. The Mre11 complex: at the crossroads of DNA repair and DNA checkpoint signaling. Nat. Rev. Mol. Cell. Biol. 3 (2002) 317-327
7. Lukas C., Melander F., Stucki M., Falck J., Bekker-Jensen S., Goldberg M., Lerenthal Y., Jackson S.P., Bartek J., and Lukas J. Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention. EMBO J. 23 (2004) 2674-2683
8. Lavin M.F. The Mre11 complex and ATM: a two-way functional interaction in recognising and signalling DNA double strand breaks. DNA Repair 3 (2004) 1515-1520
9. Uziel T., Lerenthal Y., Moyal L., Andegeko Y., Mittelman L., and Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22 (2003) 5612-5621
10. van den Bosch M., Bree R.T., and Lowndes N.F. The MRN complex: coordinating and mediating the response to broken chromosomes. EMBO Rep. 4 (2003) 844-849
11. Stracker T.H., Theunissen J.W., Morales M., and Petrini J.H. The Mre11 complex and the metabolism of chromosome breaks: the importance of communicating and holding things together. DNA Repair 3 (2004) 845-854
12. Williams R.S., Williams J.S., and Tainer J.A. Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin template. Biochem. Cell Biol. 85 (2007) 509-520
13. Maser R.S., Mirzoeva O.K., Wells J., Olivares H., Williams B.R., Zinkel R.A., Farnham P.J., and Petrini J.H. Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis. Mol. Cell. Biol. 21 (2001) 6006-6016
14. Costanzo V., Robertson K., Bibikova M., Kim E., Grieco D., Gottesman M., Carroll D., and Gautier J. Mre11 protein complex prevents double-strand break accumulation during chromosomal DNA replication. Mol. Cell. 8 (2001) 137-147
15. Borde V. The multiple roles of the Mre11 complex for meiotic recombination. Chromosome Res. 15 (2007) 551-563
16. Chai W., Sfeir A.J., Hoshiyama H., Shay J.W., and Wright W.E. The involvement of the Mre11/Rad50/Nbs1 complex in the generation of G-overhangs at human telomeres. EMBO Rep. 7 (2006) 225-230
17. Slijepcevic P. The role of DNA damage response proteins at telomeres-an "integrative" model. DNA Repair 5 (2006) 1299-1306
18. Reina-San-Martin B., Nussenzweig M.C., Nussenzweig A., and Difilippantonio S. Genomic instability, endoreduplication and diminished Ig class-switch recombination in B cells lacking Nbs1. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 1590-1595
19. Lähdesmäki A., Taylor A.M., Chrzanowska K.H., and Pan-Hammarström Q. Delineation of the role of the Mre11 complex in class switch recombination. J. Biol. Chem. 279 (2004) 16479-16487
20. Marcelain K., De la Torre C., González P., and Pincheira J. Roles of nibrin and ATM/ATR kinases on the G2 checkpoint under endogenous or radio-induced DNA damage. Biol. Res. 38 (2005) 179-185
21. Olson E., Nievera C.J., Liu E., Lee A.Y.L., Chen L., and Wu X. The Mre11 complex mediates the S-phase checkpoint through an interaction with replication protein A. Mol. Cell. Biol. 27 (2007) 6053-6067
22. Difilippantonio S., Celeste A., Kruhlak M., Lee Y., Difilippantonio M.J., Feigenbaum L., Jackson S.P., McKinnon P.J., and Nussenzweig A. Distinct domains in Nbs1 regulate irradiation-induced checkpoints and apoptosis. J. Exp. Med. 204 (2007) 1003-1011
23. Falck J., Petrini J.H., Williams B.R., Lukas J., and Bartek J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat. Genet. 30 (2002) 290-294
24. Carson C.T., Schwartz R.A., Stracker T.H., Lilley C.E., Lee D.V., and Weitzman M.D. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J. 22 (2003) 6610-6620
25. Stracker T.H., Morales M., Couto S.S., Hussein H., and Petrini J.H. The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex. Nature 447 (2007) 218-221
26. Morales M., Theunissen J.W., Kim C.F., Kitagawa R., Kastan M.B., and Petrini J.H. The Rad50S allele promotes ATM-dependent DNA damage responses and suppresses ATM deficiency: implications for the Mre11 complex as a DNA damage sensor. Genes Dev. 19 (2005) 3043-3054
27. Zhu J., Petersen S., Tessarollo L., and Nussenzweig A. Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr. Biol. 11 (2001) 105-109
28. Xiao Y., and Weaver D.T. Conditional gene targeted deletion by Cre recombinase demonstrates the requirement for the double-strand break repair Mre11 protein in murine embryonic stem cells. Nucleic Acids Res. 25 (1997) 2985-2991
29. Luo G., Yao M.S., Bender C.F., Mills M., Bladl A.R., Bradley A., and Petrini J.H.J. Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development and sensitivity to ionizing radiation. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 7376-7381
30. Mavrou A., Tsangaris G.T., Roma E., and Kolialexi A. The ATM gene and ataxia telangiectasia. Anticancer Res. 28 (2008) 401-405
31. Frappart P.O., and McKinnon P.J. Ataxia-telangiectasia and related diseases. Neuromol. Med. 8 (2006) 495-511
32. Dumon-Jones V., Frappart P.O., Tong W.M., Sajithlal G., Hulla W., Schmid G., Herceg Z., Digweed M., and Wang Z.Q. Nbn heterozytosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis. Cancer Res. 63 (2003) 7263-7269
33. S/S mice. Genes Dev. 16 (2002) 2237-2251
34. Seemanová E. An increased risk for malignant neoplasms in heterozygotes for a syndrome of microcephaly, normal intelligence, growth retardation, remarkable facies, immunodeficiency and chromosomal instability. Mutat. Res. 238 (1990) 321-324
35. Krüger L., Demuth I., Neitzel H., Varon R., Sperling K., Chrzanowska K.H., Seemanova E., and Digweed M. Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein. Carcinogenesis 28 (2007) 107-111
36. Angèle S., Treilleux I., Brémond A., Tanière P., and Hall J. Altered expression of DNA double-strand break detection and repair proteins in breast carcinomas. Histopathology 43 (2003) 347-353
37. Maser R.S., Monsen K.J., Nelms B.E., and Petrini J.H. hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol. Cell. Biol. 17 (1997) 6087-6096
38. Sakata K.I., Matsumoto Y., Tauchi H., Satoh M., Oouchi A., Nagakura H., Koito K., Hosoi Y., Suzuki N., Komatsu K., and Hareyama M. Expression of genes involved in repair of DNA double-strand breaks in normal and tumor tissues. Int. J. Radiat. Oncol. Biol. Phys. 49 (2001) 161-167
39. Angèle S., Jones C., Reis Filho J.S., Fulford L.G., Treilleux I., Lakhani S.R., and Hall J. Expression of ATM, p53 and the MRE11-Rad50-NBS1 complex in myoepithelial cells from benign and malignant proliferations of the breast. J. Clin. Pathol. 57 (2004) 1179-1184
40. Chen Y.C., Su Y.N., Chou P.C., Chiang W.C., Chang M.C., Wang L.S., Teng S.C., and Wu K.J. Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt. J. Biol. Chem. 280 (2005) 32505-32511
41. Ehlers J.P., and Harbour J.W. NBS1 expression as a prognostic marker in uveal melanoma. Clin. Cancer Res. 11 (2005) 1849-1853
42. Yang M.H., Chiang W.C., Chou T.Y., Chang S.Y., Chen P.M., Teng S.C., and Wu K.J. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation. Clin. Cancer Res. 12 (2006) 507-515
43. Chiang Y.C., Teng S.C., Su Y.N., Hsieh F.J., and Wu K.J. c-Myc directly regulates the transcription of the NBS1 gene involved in DNA double-strand break repair. J. Biol. Chem. 278 (2003) 19286-19291
44. WAF1/CIP1- dependent manner: its potential utility in local gene therapy of tumor. Cell Growth Differ. 12 (2001) 243-254
45. Kook H., Ahn K.Y., Lee S.E., Na H.S., and Kim K.K. Nitric oxide-dependent cytoskelatal changes and inhibition of endothelial cell migration contribute to the suppression of angiogenesis by RAD50 gene transfer. FEBS Lett. 553 (2003) 56-62
46. The International Nijmegen Breakage Syndrome Study Group, Nijmegen breakage syndrome, Arch. Dis. Child. 82 (2000) 400-406.
47. Steffen J., Varon R., Mosor M., Maneva G., Maurer M., Stumm M., Nowakowska D., Rubach M., Kosakowska E., Ruka W., Nowecki Z., Rutkowski P., Demkow T., Sadowska M., Bidziński M., Gawrychowski K., and Sperling K. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int. J. Cancer 11 (2004) 67-71
48. Seemanová E., Jarolim P., Seeman P., Varon R., Digweed M., Swift M., and Sperling K. Cancer risk of heterozygotes with the NBN founder mutation. J. Natl. Cancer Inst. 99 (2007) 1875-1880
49. Chrzanowska K.H., Piekutowska-Abramczuk D., Popowska E., Gładkowska-Dura M., Małdyk J., Syczewska M., Krajewska-Walasek M., Goryluk-Kozakiewicz B., Bubała H., Gadomski A., Gaworczyk A., Kazanowska B., Kołtan A., Kuźmicz M., Luszawska-Kutrzeba T., Maciejka-Kapuścińska L., Stolarska M., Stefańska K., Sznurkowska K., Wakulińska A., Wieczorek M., Szczepański T., and Kowalczyk J. Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies. Int. J. Cancer 118 (2006) 1269-1274
50. Resnick I.B., Kondratenko I., Pashanov E., Maschan A.A., Karachunsky A., Togoev O., Timakov A., Polyakov A., Tverskaya S., Evgrafov O., and Roumiantsev A.G. 657del5 mutation in the gene for Nijmegen breakage syndrome (NBS1) in a cohort of Russian children with lymphoid tissue malignancies and controls. Am. J. Med. Genet. 120 (2003) 174-179
51. Mosor M., Ziółkowska I., Pernak-Schwarz M., Januszkiewicz-Lewandowska D., and Nowak J. Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia. Leukemia 20 (2006) 1454-1456
52. Steffen J., Maneva G., Popławska L., Varon R., Mioduszewska O., and Sperling K. Increased risk of gastrointestinal lymphoma in carriers of the 657del5 NBS1 gene mutation. Int. J. Cancer 119 (2006) 2970-2973
53. Stanulla M., Stümm M., Dieckvoss B.O., Seidemann K., Schemmel V., Brechlin A.M., Schrappe M., Welte K., and Reiter A. No evidence for a major role of heterozygous deletion 657del5 within the NBS1 gene in the pathogenesis of non-Hodgkin's lymphoma of childhood and adolescence. Br. J. Haematol. 109 (2000) 117-120
54. Rischewski J., von Bismarck P., Kabisch H., Janka-Schaub G., Obser T., and Schneppenheim R. The common deletion 657del5 in the nibrin gene is not a major risk factor for B or T cell non-Hodgkin lymphoma in a pediatric population. Leukemia 14 (2000) 1528-1529
55. Cerosaletti K.M., Morrison V.A., Sabath D.E., Willerford D.M., and Concannon P. Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma. Genes Chromosomes Cancer 35 (2002) 282-286
56. Stumm M., von Ruskowsky A., Siebert R., Harder S., Varon R., Wieacker P., and Schlegelberger B. No evidence for deletions of the NBS1 gene in lymphomas. Cancer Genet. Cytogenet. 126 (2001) 60-62
57. G.M. Taylor, H.P. O'Brien, M.V. Greaves, P.F. Ravetto, O.B. Eden, Correspondence re: R. Varon et al., Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia. Cancer Res., 61 (2001) 3570-3572, Cancer Res. 63 (2003) 6563-6564.
58. Steffen J., Nowakowska D., Niwińska A., Czapczak D., Kluska A., Pia{ogonek}tkowska M., Wiśniewska A., and Paszko Z. Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. Int. J. Cancer 119 (2006) 472-475
59. Bogdanova N., Feshchenko S., Schürmann P., Waltes R., Wieland B., Hillemanns P., Rogov Y.I., Dammann O., Bremer M., Karstens J.H., Sohn C., Varon R., and Dörk T. Nijmegen breakage syndrome mutations and risk of breast cancer. Int. J. Cancer 122 (2008) 802-806
60. Górski B., De{ogonek}bniak T., Masojć B., Mierzejewski M., Me{ogonek}drek K., Cybulski C., Jakubowska A., Kurzawski G., Chosia M., Scott R., and Lubiński J. Germline 657del5 mutation in the NBS1 gene in breast cancer patients. Int. J. Cancer 106 (2003) 379-381
61. Buslov K.G., Iyevleva A.G., Chekmariova E.V., Suspitsin E.N., Togo A.V., Kuligina E.S., Sokolenko A.P., Matsko D.E., Turkevich E.A., Lazareva Y.R., Chagunava O.L., Bit-Sava E.M., Semiglazov V.F., Devilee P., Cornelisse C., Hanson K.P., and Imyanitov E.N. NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia. Int. J. Cancer 114 (2005) 585-589
62. Rożnowski K., Januszkiewicz-Lewandowska D., Mosor M., Pernak M., Litwiniuk M., and Nowak J. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer. Breast Cancer Res. Treat. 110 (2008) 343-348
63. Górski B., Cybulski C., Huzarski T., Byrski T., Gronwald J., Jakubowska A., Stawicka M., Gozdecka-Grodecka S., Szwiec M., Urbański K., Mituś J., Marczyk E., Dziuba J., Wandzel P., Surdyka D., Haus O., Janiszewska H., De{ogonek}bniak T., Tołoczko-Grabarek A., Me{ogonek}drek K., Masojć B., Mierzejewski M., Kowalska E., Narod S.A., and Lubiński J. Breast cancer predisposing alleles in Poland. Breast Cancer Res. Treat. 92 (2005) 19-24
64. Kanka C., Brożek I., Skalska B., Siemia{ogonek}tkowska A., and Limon J. Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland. Anticancer Res. 27 (2007) 3015-3018
65. Sokolenko A.P., Rozanov M.E., Mitiushkina N.V., Sherina N.Y., Iyevleva A.G., Chekmariova E.V., Buslov K.G., Shilov E.S., Togo A.V., Bit-Sawa E.M., Voskresenskiy D.A., Chagunava O.L., Devilee P., Cornelisse C., Semiglazov V.F., and Imyanitov E.N. Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia. Fam. Cancer 6 (2007) 281-286
66. Plisiecka-Hałasa J., Dansonka-Mieszkowska A., Rembiszewska A., Bidziński M., Steffen J., and Kupryjańczyk J. Nijmegen breakage syndrome gene (NBS1) alterations and its protein (nibrin) expression in human ovarian tumours. Ann. Hum. Genet. 66 (2002) 353-359
67. Cybulski C., Górski B., De{ogonek}bniak T., Gliniewicz B., Mierzejewski M., Masojć B., Jakubowska A., Matyjasik J., Złowocka E., Sikorski A., Narod S.A., and Lubiński J. NBS1 is a prostate cancer susceptibility gene. Cancer Res. 64 (2004) 1215-1219
68. Hebbring S.J., Fredriksson H., White K.A., Maier C., Ewing C., McDonnell S.K., Jacobsen S.J., Cerhan J., Schaid D.J., Ikonen T., Autio V., Tammela T.L.J., Herkommer K., Paiss T., Vogel W., Gielzak M., Sauvageot J., Schleutker J., Cooney K.A., Isaacs W., and Thibodeau S.N. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 935-938
69. De{ogonek}bniak T., Górski B., Cybulski C., Jakubowska A., Kurzawski G., Lener M., Mierzejewski M., Masojć B., Me{ogonek}drek K., Kładny J., Załuga E., Maleszka R., Chosia M., and Lubiński J. Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin. Melanoma Res. 13 (2003) 365-370
70. Ziółkowska I., Mosor M., Wierzbicka M., Rydzanicz M., Pernak-Schwarz M., and Nowak J. Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Cancer Sci. 98 (2007) 1701-1705
71. Ng P.C., and Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 31 (2003) 3812-3814
72. Shimada H., Shimizu K., Mimaki S., Sakiyama T., Mori T., Shimasaki N., Yokota J., Nakachi K., Ohta T., and Ohki M. First case of aplastic anemia in a Japanese child with a homozygous missense mutation in the NBS1 gene (I171V) associated with genomic instability. Hum. Genet. 115 (2004) 372-376
73. N. Bogdanova, P. Schürmann, R. Waltes, S. Feshchenko, I.V. Zalutsky, M. Bremer, T. Dörk, NBS1 variant I171V and breast cancer risk, Breast Cancer Res. Treat. (2007).
74. Varon R., Reis A., Henze G., Einsiedel H.G.V., Sperling K., and Seeger K. Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia (ALL). Cancer Res. 61 (2001) 3570-3572
75. Nowak J., Mosor M., Ziółkowska I., Wierzbicka M., Pernak-Schwarz M., Przyborska M., Rożnowski K., Pławski A., Słomski R., and Januszkiewicz D. Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours. Eur. J. Cancer 44 (2008) 627-630
76. Heikkinen K., Karppinen S.M., Soini Y., Mäkinen M., and Winqvist R. Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility. J. Med. Genet. 40 (2003) e131
77. Heikkinen K., Rapakko K., Karppinen S.M., Erkko H., Knuutila S., Lundán T., Mannermaa A., Børresen-Dale A.L., Borg A., Barkardottir R.B., Petrini J., and Winqvist R. RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis 27 (2006) 1593-1599
78. di Masi A., Viganotti M., Polticelli F., Ascenzi P., Tanzarella C., and Antoccia A. The R215W mutation in NBS1 impairs gamma-H2AX binding and affects DNA repair: molecular bases for the severe phenotype of 657del5/R215W Nijmegen breakage syndrome patients. Biochem. Biophys. Res. Commun. 369 (2008) 835-840
79. Seemanová E., Sperling K., Neitzel H., Varon R., Hadac J., Butova O., Schröck E., Seeman P., and Digweed M. Nijmegen breakage syndrome (NBS) with neurological abnormalities and without chromosomal instability. J. Med. Genet. 43 (2006) 218-224
80. Lu J., Wei Q., Bondy M.L., Li D., Brewster A., Shete S., Yu T.K., Sahin A., Meric-Bernstam F., Hunt K.K., Singletary S.E., Ross M.I., and Wang L.E. Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women ≤55 years. Carcinogenesis 27 (2006) 2209-2216
81. Lan Q., Shen M., Berndt S.I., Bonner M.R., He X., Yeager M., Welch R., Keohavong P., Donahue M., Hainaut P., and Chanock S. Smoky coal exposure, NBS1 polymorphisms, p53 protein accumulation, and lung cancer risk in Xuan Wei, China. Lung Cancer 49 (2005) 317-323
82. Ryk C., Kumar R., Thirumaran R.K., and Hou S.M. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1 and the risk for lung cancer in never- and ever-smokers. Lung Cancer 54 (2006) 285-292
83. Thirumaran R.K., Bermejo J.L., Rudnai P., Gurzau E., Koppova K., Goessler W., Vahter M., Leonardi G.S., Clemens F., Fletcher T., Hemminki K., and Kumar R. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis 27 (2006) 1676-1681
84. Zhang L., Zhang Z., and Yan W. Single nucleotide polymorphismsm for DNA repair genes in breast cancer patients. Clin. Chim. Acta 359 (2005) 150-155
85. Auranen A., Song H., Waterfall C., DiCioccio R.A., Kuschel B., Kjaer S.K., Hogdall E., Hogdall C., Stratton J., Whittemore A.S., Easton D.F., Ponder B.A.J., Novik K.L., Dunning A.M., Gayther S., and Pharoah P.D.P. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. Int. J. Cancer 117 (2005) 611-618
86. Medina P.P., Ahrendt S.A., Pollan M., Fernandez P., Sidransky D., and Sanchez-Cespedes M. Screening of homologous recombination gene polymorphisms in lung cancer patients reveal an association of the NBS1-185Gln variant and p53 gene mutations. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 699-704
87. Zienolddiny S., Campa D., Lind H., Ryberg D., Skaug V., Stangeland L., Phillips D.H., Canzian F., and Haugen A. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27 (2006) 560-567
88. Figueroa J.D., Malats N., Rothman N., Real F.X., Silverman D., Kogevinas M., Chanock S., Yeager M., Welch R., Dosemeci M., Tardón A., Serra C., Carrato A., Garcia-Closas R., Castaño-Vinyals G., and Garcia-Closas M. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis 28 (2007) 1788-1793
89. Sanyal S., Festa F., Sakano S., Zhang Z., Steineck G., Norming U., Wijkström H., Larsson P., Kumar R., and Hemminki K. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25 (2004) 729-734
90. Ebi H., Matsuo K., Sugito N., Suzuki M., Osada H., Tajima K., Ueda R., and Takahashi T. Novel NBS1 heterozygous germ line mutation causing MRE-11 binding domain loss predisposes to common types of cancer. Cancer Res. 67 (2007) 11158-11165
91. Varon R., Schoch C., Reis A., Hiddemann W., Sperling K., and Schnittger S. Mutation analysis of the Nijmegen Breakage Syndrome gene (NBS1) in nineteen patients with acute myeloid leukemia with complex karyotypes. Leuk. Lymphoma 44 (2003) 1931-1934
92. Fukuda T., Sumiyoshi T., Takahashi M., Kataoka T., Asahara T., Inui H., Watatani M., Yasutomi M., Kamada N., and Miyagawa K. Alterations of the double-strand break repair gene MRE11 in cancer. Cancer Res. 61 (2001) 23-26
93. J. Tommiska, S. Seal, A. Renwick, R. Barfoot, L. Baskcomb, H. Jayatilake, J. Bartkova, J. Tallila, M. Kaare, A. Tamminen, P. Heikkilä, D.G. Evans, D. Eccles, Breast Cancer Susceptibility Collaboration (UK), K. Aittomäki, C. Blomqvist, J.Bartek, M.R. Stratton, H. Nevanlinna, N. Rahman, Evaluation of RAD50 in familial breast cancer predisposition, Int. J. Cancer 118 (2006) 2911-2916.
94. van der Heijden M.S., Brody J.R., Elghalbzouri-Maghrani E., Zdzienicka M.Z., and Kern S.E. Does tumorigenesis select for or against mutations of the DNA repair-associated genes BRCA2 and MRE11? Considerations from somatic mutations in microsatellite unstable (MSI) gastrointestinal cancers. BMC Genet. 7 (2006) 3
95. Giannini G., Rinaldi C., Ristori E., Ambrosini M.I., Cerignoli F., Viel A., Bidoli E., Berni S., D'Amati G., Scambia G., Frati L., Screpanti I., and Gulino A. Mutations of an intronic repeat induce impaired MRE11 expression in primary human cancer with microsatellite instability. Oncogene 23 (2004) 2640-2647
96. Giannini G., Ristori E., Cerignoli F., Rinaldi C., Zani M., Viel A., Ottini L., Crescenzi M., Martinotti S., Bignami M., Frati L., Screpanti I., and Gulino A. Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep. 3 (2002) 248-254
97. Koh K.H., Kang H.J., Li L.S., Kim N.G., You K.T., Yang E., Kim H., Kim H.J., Yun C.O., Kim K.S., and Kim H. Impaired nonhomologous end-joining in mismatch repair-deficient colon carcinomas. Lab. Invest. 85 (2005) 1130-1138
98. Ottini L., Falchetti M., Saieva C., De Marco M., Masala G., Zanna I., Paglierani M., Giannini G., Gulino A., Nesi G., Costantini R.M., and Palli D. MRE11 expression is impaired in gastric cancer with microsatellite instability. Carcinogenesis 25 (2004) 2337-2343
99. Ikenoue T., Togo G., Nagai K., Ijichi H., Kato J., Yamaji Y., Okamoto M., Kato N., Kawabe T., Tanaka A., Matsumura M., Shiratori Y., and Omata M. Frameshift mutations at mononucleotide repeats in RAD50 recombinational DNA repair gene in colorectal cancers with microsatellite instability. Jpn. J. Cancer Res. 92 (2001) 587-591
100. Kim N.G., Choi Y.R., Baek M.J., Kim Y.H., Kang H., Kim N.K., Min J.S., and Kim H. Frameshift mutations in coding mononucleotide repeats of the hRAD50 gene in gastrointestinal carcinomas with microsatellite instability. Cancer Res. 61 (2001) 36-38
101. Duval A., Rolland S., Compoint A., Tubacher E., Iacopetta B., Thomas G., and Hamelin R. Evolution of instability at coding and non-coding repeat sequences in human MSI-H colorectal cancers. Hum. Mol. Genet. 10 (2001) 513-518
102. Antoniou A.C., and Easton D.F. Models of genetic susceptibility to breast cancer. Oncogene 25 (2006) 5898-5905
103. ATLD1/ATLD1 mice. Mol. Cell. 12 (2003) 1511-1523